Correction: Advances and potential pitfalls of oncolytic viruses expressing immunomodulatory transgene therapy for malignant gliomas
A Correction to this paper has been published: https://doi.org/10.1038/s41419-020-2696-5.
Main Authors: | Qing Zhang, Fusheng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2020-11-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-020-03216-z |
Similar Items
-
Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
by: Shan Jiang, et al.
Published: (2023-10-01) -
Oncolytic viruses for the treatment of malignant glioma
by: Hong⁃yu LIU, et al.
Published: (2020-02-01) -
Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
by: Yogesh R. Suryawanshi, et al.
Published: (2021-07-01) -
Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
by: Mingming Hu, et al.
Published: (2023-11-01) -
Potentiation of immunomodulatory antibody therapy with oncolytic viruses for treatment of cancer
by: Dmitriy Zamarin, et al.
Published: (2014-01-01)